Seera Holding Group heads into its August 24 earnings release with an unusual amount of insider buying on the tape and a price that has recovered sharply from May lows — setting up a genuine test of whether the support that board members signalled has been warranted.
The insider story is the most compelling angle this week. Two board members spent the better part of three months accumulating shares at prices between SAR 20.22 and SAR 21.25. Director Abdul Aziz Al Qasabi made repeated purchases in May, adding roughly 204,000 shares across multiple days. Independent Director Fawaz Al Rajhi was more aggressive — his largest single purchase, on May 14, totalled nearly 295,000 shares worth approximately USD 1.67 million. Combined, net insider buying over the past 90 days reached 629,000 shares valued at roughly USD 3.5 million. All transactions were at prices below the current SAR 21.54 close, meaning the directors are sitting on modest paper gains heading into Monday's print.
The lending market is quiet, which is notable given the company's travel and hospitality profile. Availability is ample at around 234% — more than two shares available to borrow for every one already lent out — and that level has held almost unchanged for the past month. The 52-week tightest availability was roughly 48%, so the current reading is nowhere near squeeze territory. Cost-to-borrow data is stale (last captured July 16 at just over 10%), but the sustained availability looseness suggests no fresh wave of short selling has arrived ahead of the release. The ORTEX short score drifted slightly lower over the past two weeks, moving from 42.5 to 42.4 — barely a rounding error, confirming that bearish conviction is not building into this event.
The Street's view is limited but not alarming. The consensus price target is SAR 23.26, implying roughly 8% upside from Thursday's close. There have been no recent analyst rating changes, and the factor score picture is mixed: EPS momentum over 30 days ranks in the 79th percentile — genuinely strong — but the 90-day EPS momentum score collapses to the 3rd percentile, flagging that the near-term improvement sits against a much weaker medium-term earnings trend. The valuation is undemanding at roughly 41x trailing earnings, though the price-to-book multiple of 0.96 reflects the market still valuing the company at below replacement cost. EV/EBITDA runs at about 7.9x, up modestly over the past month as the stock recovered.
The earnings history offers limited comfort either way. The last four prints produced swings of +5%, -2.3%, -2.8%, and +0.9% on the day — with five-day moves equally scattered. The most recent result, announced on August 9, produced a single-day gain of just under 1% and a five-day gain of 1.4%. That muted reaction suggests the market is neither chasing the stock higher nor punishing disappointments sharply — at least in the short run. The five-day move after the June 2 announcement was a 4.2% decline, the sharpest directional move in the dataset.
Monday's result will determine whether the directors' three-month accumulation at the SAR 20–21 level looks prescient or premature — and whether the modest analyst target premium survives contact with the actual numbers.
See the live data behind this article on ORTEX.
Open 1810 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
